Daan Gene Co., Ltd. (SHE:002030)

China flag China · Delayed Price · Currency is CNY
6.30
-0.04 (-0.63%)
At close: Feb 13, 2026
Market Cap8.84B +12.1%
Revenue (ttm)765.48M -17.7%
Net Income-563.95M
EPS-0.40
Shares Out1.40B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,175,200
Average Volume67,120,896
Open6.34
Previous Close6.34
Day's Range6.28 - 6.38
52-Week Range5.11 - 8.20
Beta0.39
RSI44.80
Earnings DateApr 3, 2026

About Daan Gene

Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coronavirus disease (COVID-19), pharmacogenomics, viral transport medium, human papillomavirus, human immunodeficiency virus, respiratory infections, publi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 1,730
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002030
Full Company Profile

Financial Performance

Financial Statements